Global Refurbished Medical Imaging Devices Market Report, 2025-2032

The Global Refurbished Medical Imaging Devices Market was worth USD 5,976 million in 2025. The figure reflects the triangulated value of refurbished CT, MRI, X-ray, ultrasound, nuclear imaging and related systems transacted globally through OEM-certified programs, independent refurbishers and dealer networks. It is supported by a demand-side benchmark of approximately USD 51 billion for the new diagnostic imaging equipment market and external refurbished-imaging estimates concentrated around the USD 5.2-7.0 billion range. Refurbished systems therefore represent a meaningful but still minority component of total imaging equipment capital expenditure.

The market is projected to reach USD 11,207 million by 2032, representing a 9.40% CAGR from the 2025 base. The supplied forecast reaches USD 9,364 million by 2030 and is extended through 2032 on the same central value-growth trajectory. Unit growth is modeled near 7.5%, with additional value growth coming from rising blended system value and a greater contribution from CT, MRI and advanced imaging platforms. Growth should remain strongest where diagnostic access is expanding faster than budgets for brand-new high-end scanners.

Profit pools are likely to move away from undifferentiated used-equipment resale toward certified refurbishment, installation, software upgrades, parts, maintenance and asset-recovery services. OEM programs from GE HealthCare, Siemens Healthineers, Philips and Canon Medical Systems illustrate the formalization of circular procurement, while independent platforms such as Probo Medical and Block Imaging combine equipment sales with service capabilities. Higher-value CT and MRI systems generate more attractive revenue per transaction, but they also require greater engineering expertise, logistics coordination and parts support, increasing barriers to scaled participation.

Technology obsolescence is the most important structural risk, particularly where older refurbished systems cannot economically support current AI, reconstruction, cybersecurity or software requirements. Parts availability and local engineering capacity create a second constraint because system downtime can erase the original capital-saving advantage. Regulatory heterogeneity adds another layer of execution risk: IEC 63077 provides an international refurbishment framework, but national import, servicing and remanufacturing rules differ. Markets with weak lifecycle support may therefore grow more slowly than demand indicators alone suggest.

North America offers the largest current revenue pool, while Asia Pacific provides the strongest growth profile. North America generated approximately USD 2,094 million in 2023 and represented 47.7% of the global market. Europe followed at roughly USD 1,126 million. Asia Pacific was smaller at approximately USD 769 million but is forecast to grow at 11.5% CAGR through 2030, faster than North America and Europe. India is among the strongest country-level growth markets, reflecting lower imaging penetration and substantial sensitivity to equipment capital cost.

The strongest long-term demand factor is the widening requirement for diagnostic imaging capacity as disease burden and healthcare utilization increase. IARC recorded almost 20 million new cancer cases globally in 2022 and projects approximately 35 million annual cases by 2050, a 77% increase. Imaging remains central to detection, staging, treatment planning and follow-up for many disease areas. In markets where healthcare infrastructure expands faster than capital budgets, refurbished CT, MRI, X-ray and ultrasound systems can accelerate capacity deployment without requiring equivalent spending on brand-new platforms.